Lung Cancer Stage I
Showing 1 - 25 of >10,000
Lung Cancer, Nonsmall Cell, Lung Cancer Stage I, Lung Cancer Stage II Trial in Columbia (Breathe Easier Progressive Web
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- +3 more
- Breathe Easier Progressive Web Application
-
Columbia, South CarolinaUniversity of South Carolina
Sep 22, 2023
Lung Cancer Stage I, Quality of Life Trial in Fuzhou
Recruiting
- Lung Cancer Stage I
- Quality of Life
-
Fuzhou, Fujian, ChinaMaohui Chen
Aug 28, 2023
Lung Cancer Stage I Trial in Montréal (VATS/RATS lobectomy)
Recruiting
- Lung Cancer Stage I
- VATS/RATS lobectomy
-
Montréal, Quebec, CanadaCHUM
Apr 14, 2023
NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- Stereotactic body radiotherapy
- +2 more
- (no location specified)
Jul 5, 2022
Stage I - II Primary Lung Cancer, Stage I Lung Cancer, Stage II Lung Cancer Trial in Boston (AveCure 16 Gauge Flexible Microwave
Not yet recruiting
- Stage I - II Primary Lung Cancer
- +5 more
- AveCure 16 Gauge Flexible Microwave Ablation Probe
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 11, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +6 more
- Biopsy
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)
Completed
- Lung Cancer
- Metastatic Cancer
- Cryotherapy (PTC)
- Prednisone
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 29, 2022
Lung Cancer, Lung Cancer Stage I, Lung Cancer Stage II Trial in Mission Viejo, New York (CivaSheet)
Recruiting
- Lung Cancer
- +2 more
- CivaSheet
-
Mission Viejo, California
- +2 more
May 23, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- AVENIO ctDNA Surveillance Kit
- Durvalumab
-
Stanford, CaliforniaStanford University
Mar 25, 2022
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
NSCLC, NSCLC, Lung Cancer Trial in United States (Durvalumab, Stereotactic Body Radiation Therapy)
Recruiting
- NSCLC
- +7 more
- Durvalumab
- Stereotactic Body Radiation Therapy
-
Hartford, Connecticut
- +8 more
Jul 7, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022
NSCLC Stage I Trial in Baltimore (Post-SABR Biopsy)
Recruiting
- Non-small Cell Lung Cancer Stage I
- Post-SABR Biopsy
-
Baltimore, MarylandBayview Medical Center
Nov 23, 2021
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
May 20, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,
Active, not recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2022
Non-metastatic, Non-recurrent Lung and Esophageal Cancer
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +55 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 5, 2023
Early Stage NSCLC, NSCLC Trial in Saint Louis (Computed tomography-guided stereotactic adaptive radiotherapy, ETHOS)
Not yet recruiting
- Early Stage Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Computed tomography-guided stereotactic adaptive radiotherapy
- ETHOS
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2023
NSCLC Stage I Trial in Shanghai (traditional Chinese medicine and ablation in the primary tumor sites, ablation)
Recruiting
- Non-small Cell Lung Cancer Stage I
- traditional Chinese medicine and ablation in the primary tumor sites
- ablation
-
Shanghai, Shanghai, ChinaShanghai 10th People's Hospital
Oct 27, 2021
NSCLC, Stage I Trial in Tianjin (Osimertinib)
Recruiting
- NSCLC, Stage I
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Jan 6, 2023